Strong Growth Ahead: Drug Delivery Devices Market Size To Grow At Arecord 6.6% Cagr By 2029

The Drug Delivery Devices Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

How Big Is the Drug Delivery Devices Market Size Expected to Be by 2034?
The market size for drug delivery devices has experienced significant growth in the past few years. There is an anticipated rise from $91.03 billion in 2024 to $96.73 billion in 2025, with a compound annual growth rate (CAGR) of 6.3%. Factors contributing to the growth during the historical period include the surging elderly population, expansion in the healthcare facilities, economic elevation in developing markets, and an enhancement in healthcare spending.

Significant expansion is projected for the drug delivery devices market size in the up-coming years, estimated to rise to $124.82 billion by 2029, with a compound annual growth rate (CAGR) of 6.6%. The anticipated growth over this period is primarily due to factors such as the rising occurrence of chronic diseases, an influx in demand for injectables, as well as growing needs for drug delivery devices, coupled with the sudden surge in severe infections. Some noteworthy trends in the forecast term are investments in microneedle drug technology for medicine administration, advancement in the research and development of self-injectable drug delivery gadgets, an emphasis on mergers and acquisitions, and funding in the development of wearable drug delivery devices.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2833

What Are the Emerging Segments Within the Drug Delivery Devices Market?
The drug delivery devices market covered in this report is segmented -

1) By Route Of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery
2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings
3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications

Subsegments:
1) By Oral Drug Delivery: Tablets and Capsules, Oral Sprays, Oral Liquids, Oral Disintegrating Tablets
2) By Injectable Drug Delivery: Syringes (manual and auto-disable), Vials and Cartridges, Pen Injectors, Infusion Pumps
3) By Topical Drug Delivery: Creams and Ointments, Transdermal Patches, Gels and Lotions, Powders
4) By Ocular Drug Delivery: Eye Drops, Ocular Inserts, Contact Lens Drug Delivery Systems
5) By Pulmonary Drug Delivery: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers
6) By Nasal Drug Delivery: Nasal Sprays, Nasal Powders, Nasal Drops
7) By Transmucosal Drug Delivery: Buccal Tablets, Sublingual Tablets, Mucoadhesive Films
8) By Implantable Drug Delivery: Drug-Implantable Devices, Biodegradable Implants, Reservoir-based Implants

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2833&type=smp

What Long-Term Drivers Are Shaping Drug Delivery Devices Market Trends?
An upsurge in chronic illnesses such as cardiovascular ailments, diabetes, cancer and other forms of disease is anticipated to bolster the drug delivery devices market. To illustrate, the National Library of Medicine, a medical library managed by the U.S. federal government, indicated in January 2023 that the cohort of individuals aged 50 and above in the United States with at least one chronic condition is forecasted to escalate by 99.5%. This surge would lead to an ascension in number from 71.522 million in 2020 to 142.66 million by 2050. Numerous modes exist for the administration of medical drugs and the evolution of new drug delivery mechanisms plays a pivotal part in the pharmaceutical realm. Global research efforts for drug delivery are mounting as a consequence of the escalating prevalence of these maladies. A majority of pharmaceutical firms are zeroing in on array of drug delivery technologies to garner impressive advantages and enhance results for their products on the market. Thus, the rising incidence of chronic diseases is leading to amplified use of therapeutic drugs and remedies, and this element is anticipated to serve as a catalyst for the expansion of the drug delivery devices market.

Who Are the Top Competitors in Key Drug Delivery Devices Market Segments?
Major companies operating in the drug delivery devices market include Becton, Dickinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, 3M Company, West Pharmaceutical Services, Inc., Gerresheimer AG, Smiths Medical, Boehringer Ingelheim, SMC Ltd., Elcam Medical, Eli Lilly and Company, Injex, Novartis AG, Novo Nordisk A/S, Pfizer Inc, Sanofi Sa, Schott AG, Terumo Corporation, Teva Pharmaceuticals, Ypsomed Holding AG, F. Hoffmann-La Roche AG, GlaxoSmithKline, AstraZeneca, Congenica Ltd., UCB, Alkermes, Aptalis Pharma, Inc., Johnson & Johnson, Nektar Therapeutics, SkyePharma PLC, Pharmasyntez, NEARMEDIC PLUS LLC, Copernicus, Medtronic, Philips, Siemens, Stryker, GE Healthcare, Teleflex Medical, Gilero, Kedalion Therapeutics, MediPrint Ophthalmics, Nemera, Pendant Biosciences, Battelle Medical Devices, Merck & Co. Inc., Antares Pharma, Abbot, Allergan, Bilim Pharmaceuticals, H&T Presspart, Hovione Technology, Sorrel Medical, Syqe Medical, Julphar, ResMed Inc, Covidien plc

What Drug Delivery Devices Market Trends Are Gaining Traction Across Different Segments?
Key drug delivery device market players are concentrating on the creation of cutting-edge devices like autoinjectors with integrated connectivity to secure a competitive advantage. Autoinjectors, medically purposed instruments devised for the self-administration of a prescribed medicine dosage, are a good example. In May 2022, Jabil Healthcare, a healthcare manufacturing solutions provider based in the United States, introduced the Qfinity autoinjector platform, a novel re-usable drug delivery system. The Qfinity autoinjector platform is notable for its simple, reusable, modular nature, and offering a cost-efficient alternative to rival products in the market, promoting sustainable drug delivery for the pharmaceutical sector. Its flexible design aims to accommodate different drug volumes and viscosity levels, and provides a patient-focused format that results in up to 65% reduction in cost per injection when compared with top disposable autoinjectors. The sturdy Qfinity device can withstand over 100 injections and can be fitted with 1 mL or 2.25 mL pre-filled disposable cassettes. Moreover, its lower component and material use leads to a predicted 65% reduction in cost per injection, a carbon footprint 60% smaller, a manufacturing footprint lessened by 50%, and capital expenditure (CAPEX) reduced by an impressive 70%.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Which Regions Are Becoming Hubs for Drug Delivery Devices Market Innovation?
North America was the largest region in the drug delivery devices market in 2024. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Drug Delivery Devices Market?
2. What is the CAGR expected in the Drug Delivery Devices Market?
3. What Are the Key Innovations Transforming the Drug Delivery Devices Industry?
4. Which Region Is Leading the Drug Delivery Devices Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.